Hypophosphatemic rickets: A rare complication of congenital melanocytic nevus syndrome.
fibroblast growth factor 23
hypophosphatemic rickets
multiple congenital melanocytic nevi
Journal
Pediatric dermatology
ISSN: 1525-1470
Titre abrégé: Pediatr Dermatol
Pays: United States
ID NLM: 8406799
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
pubmed:
12
3
2020
medline:
15
5
2021
entrez:
12
3
2020
Statut:
ppublish
Résumé
We report the case of a child who presented with a giant melanocytic nevus with numerous satellite nevi at birth and developed hypophosphatemic rickets due to excessive secretion of the FGF23 hormone. A NRAS c.182A>G (Q61R) mutation was identified in the lesional skin. The functional outcome was favorable with medical treatment.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
541-544Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Bauer J, Curtin JA, Pinkel D, Bastian BC. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol. 2007;127:179-182.
Kinsler VA, Thomas AC, Ishida M, et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol. 2013;133:2229-2236.
Martins da Silva V, Martinez-Barrios E, Tell-Martí G, et al. Genetic abnormalities in large to giant congenital nevi: beyond NRAS mutations. J Invest Dermatol. 2019;139:900-908.
Waelchli R, Aylett SE, Atherton D, Thompson DJ, Chong WK, Kinsler VA. Classification of neurological abnormalities in children with congenital melanocytic naevus syndrome identifies magnetic resonance imaging as the best predictor of clinical outcome. Br J Dermatol. 2015;173:739-750.
Kinsler V, Shaw AC, Merks JH, Hennekam RC. The face in congenital melanocytic nevus syndrome. Am J Med Genet A. 2012;158A:1014-1019.
Ovejero D, Lim YH, Boyce AM, et al. Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment. Osteoporos Int. 2016;27:3615-3626.
Lim YH, Ovejero D, Sugarman JS, et al. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. Hum Mol Genet. 2014;15(23):397-407.
Ramesh R, Shaw N, Miles EK, et al. Mosaic NRAS Q61R mutation in a child with giant congenital melanocytic naevus, epidermal naevus syndrome and hypophosphataemic rickets. Clin Exp Dermatol. 2017;42:75-79.
Shieh CC, Wang PJ. Giant nevocellular nevi with rickets and brainstem tumor. Pediatr Neurol. 1991;7:452-454.
Gathwala G, Dalal P, Dalal JS, Dayal S, Singh G. Giant congenital melanocytic nevi: a rare association with hypophosphatemic rickets. Indian J Pediatr. 2013;80:430-431.
Chou Y-Y, Chao S-C, Shiue C-N, Tsai W-H, Lin S-J. Hypophosphatemic rickets associated with epidermal nevus syndrome and giant hairy nevus. J Pediatr Endocrinol Metab. 2005;18:93-95.
Aggarwal S, Sharma NN, Singhania DK, Dhoot DK. Hypophosphatemic rickets associated with giant hairy nevus. Indian J Endocrinol Metab. 2013;17(Suppl 1):S188-190.
Haffner D, Emma F, Eastwood DM, et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019;15(7):435-455.
Saito T, Fukumoto S. Fibroblast growth factor 23 (FGF23) and disorders of phosphate metabolism. Int J Pediatr Endocrinol. 2009;2009:496514.
Farschtschi S, Mautner V-F, Hollants S, et al. Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation. BMC Med Genet. 2015;10:16-16.